Unicycive Therapeutics, Inc. (UNCY)
5.32
-0.31
(-5.51%)
USD |
NASDAQ |
Aug 24, 16:00
5.35
+0.03
(+0.56%)
After-Hours: 20:00
Unicycive Therapeutics Max Drawdown (5Y) : 95.97% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 95.97% |
| June 30, 2026 | 95.97% |
| May 31, 2026 | 95.97% |
| April 30, 2026 | 95.97% |
| March 31, 2026 | 95.97% |
| February 28, 2026 | 95.97% |
| Date | Value |
|---|---|
| January 31, 2026 | 95.97% |
| December 31, 2025 | 95.97% |
| November 30, 2025 | 95.97% |
| October 31, 2025 | 95.97% |
| September 30, 2025 | 95.97% |
| August 31, 2025 | 95.97% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 96.33% |
| Theriva Biologics, Inc. | 99.94% |
| AbbVie, Inc. | 21.89% |
| Decoy Therapeutics, Inc. | 99.99% |
| Nkarta, Inc. | 98.27% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -49.02 |
| Beta (5Y) | 1.788 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 158.4% |
| Historical Sharpe Ratio (5Y) | -0.2057 |
| Historical Sortino (5Y) | -0.7868 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 36.19% |